Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E- EPS (ttm)-0.85 Insider Own0.01% Shs Outstand1.13B Perf Week-4.59%
Market Cap18.76B Forward P/E5.88 EPS next Y2.81 Insider Trans-86.24% Shs Float1.13B Perf Month-2.39%
Income-961.00M PEG- EPS next Q0.69 Inst Own56.89% Short Float1.98% Perf Quarter-8.49%
Sales16.81B P/S1.12 EPS this Y-3.43% Inst Trans1.14% Short Ratio3.32 Perf Half Y-3.64%
Book/sh5.35 P/B3.09 EPS next Y13.67% ROA-2.29% Short Interest22.41M Perf Year62.91%
Cash/sh2.93 P/C5.65 EPS next 5Y1.04% ROE-14.76% 52W Range9.56 - 19.31 Perf YTD58.38%
Dividend Est.- P/FCF6.85 EPS past 5Y26.63% ROI-4.22% 52W High-14.37% Beta0.80
Dividend TTM- Quick Ratio0.61 Sales past 5Y-2.68% Gross Margin49.97% 52W Low72.96% ATR (14)0.54
Dividend Ex-DateNov 27, 2017 Current Ratio0.89 EPS Y/Y TTM57.37% Oper. Margin22.45% RSI (14)40.13 Volatility3.48% 2.82%
Employees37226 Debt/Eq3.18 Sales Y/Y TTM9.85% Profit Margin-5.72% Recom1.58 Target Price23.00
Option/ShortYes / Yes LT Debt/Eq2.75 EPS Q/Q-647.09% Payout- Rel Volume0.51 Prev Close16.81
Sales Surprise4.65% EPS Surprise4.34% Sales Q/Q13.40% EarningsNov 06 BMO Avg Volume6.76M Price16.53
SMA20-2.87% SMA50-5.57% SMA2000.46% Trades Volume1,693,892 Change-1.64%
Date Action Analyst Rating Change Price Target Change
Jul-10-24Upgrade Argus Hold → Buy $20
Mar-08-24Upgrade JP Morgan Underweight → Neutral $14
Feb-12-24Upgrade Piper Sandler Neutral → Overweight $12 → $19
Jan-23-24Upgrade Jefferies Hold → Buy $10 → $14
Jan-03-24Upgrade Piper Sandler Underweight → Neutral $8 → $12
Dec-18-23Initiated HSBC Securities Buy $13
Nov-27-23Upgrade UBS Neutral → Buy $11 → $13
Jul-06-23Upgrade UBS Sell → Neutral $7 → $8
May-25-23Initiated Morgan Stanley Equal-Weight $10
May-18-23Upgrade Evercore ISI In-line → Outperform
Dec-11-24 08:00AM
Dec-05-24 06:00PM
05:13AM
Dec-04-24 02:00AM
Nov-25-24 06:00PM
02:47AM Loading…
Nov-21-24 02:47AM
Nov-15-24 09:09AM
Nov-08-24 04:30PM
09:40AM
Nov-07-24 02:06AM
Nov-06-24 04:06PM
02:41PM
02:08PM
11:30AM
10:08AM
09:30AM Loading…
09:30AM
08:57AM
07:00AM
Nov-04-24 12:00PM
Nov-01-24 03:05PM
03:00PM
09:15AM
06:40AM
Oct-31-24 02:49PM
09:26AM
08:46AM
07:30AM
Oct-25-24 09:55AM
Oct-23-24 09:40AM
09:40AM
06:35PM Loading…
Oct-22-24 06:35PM
09:20AM
07:00AM
Oct-17-24 11:07AM
Oct-11-24 12:49PM
Oct-10-24 05:19PM
Oct-09-24 03:30PM
Oct-08-24 07:00AM
Oct-07-24 09:40AM
09:40AM
Oct-04-24 06:33AM
Oct-03-24 08:30AM
Oct-01-24 08:29AM
03:38AM
Sep-30-24 04:30PM
01:01PM
Sep-24-24 08:45AM
Sep-23-24 10:33AM
01:00AM
Sep-21-24 04:15AM
04:10AM
Sep-11-24 04:30PM
Sep-10-24 04:23PM
03:34PM
Sep-06-24 01:46PM
Aug-27-24 01:01PM
Aug-26-24 05:00PM
Aug-02-24 02:22PM
Jul-31-24 04:13PM
02:11PM
12:00PM
10:00AM
09:42AM
09:40AM
07:00AM
Jul-29-24 09:16AM
Jul-25-24 01:30AM
Jul-19-24 05:12AM
Jul-18-24 08:30AM
Jul-17-24 05:21AM
Jul-12-24 08:22PM
Jul-09-24 08:22PM
Jul-02-24 06:00PM
01:33PM
Jun-28-24 11:30AM
Jun-25-24 08:00AM
Jun-24-24 04:54PM
09:50AM
Jun-22-24 09:03AM
Jun-21-24 01:06PM
Jun-14-24 07:15AM
Jun-13-24 05:35PM
Jun-11-24 08:20PM
Jun-04-24 04:05PM
Jun-01-24 02:25PM
02:20PM
May-30-24 06:35AM
May-29-24 06:38PM
May-24-24 08:11PM
May-20-24 08:25PM
May-17-24 11:00AM
09:06AM
May-16-24 06:15AM
May-15-24 09:12AM
08:15AM
May-14-24 07:00AM
May-13-24 09:40AM
09:40AM
May-09-24 11:37AM
09:33AM
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fox ChristineEVP, Head of U.S. CommercialNov 20 '24Sale16.8719,388327,08544,104Nov 21 04:04 PM
Fox ChristineOfficerNov 20 '24Proposed Sale16.8719,388327,085Nov 20 11:39 AM
Daniell RichardExec. VP, European CommercialAug 12 '24Sale17.3098,9431,711,4470Aug 13 04:09 PM
Grant AngusEVP, Business DevelopmentAug 09 '24Sale17.284,06570,2438,848Aug 13 04:06 PM
Hughes Eric ASee "Remarks"Aug 09 '24Sale17.3845,060782,9720Aug 13 04:02 PM
Daniell RichardOfficerAug 12 '24Proposed Sale17.3098,9431,711,444Aug 12 04:09 PM
Hughes Eric AOfficerAug 09 '24Proposed Sale17.3845,060782,974Aug 12 03:59 PM
Grant AngusOfficerAug 09 '24Proposed Sale17.284,06570,243Aug 09 03:59 PM
Hughes Eric ASee "Remarks"Aug 01 '24Sale17.2524,537423,28045,060Aug 05 07:35 AM
Hughes Eric AOfficerAug 01 '24Proposed Sale17.2524,537423,281Aug 01 04:00 PM
MIGNONE ROBERTODirectorJun 18 '24Sale17.03519,0008,838,570981,000Jun 21 04:05 PM
Weiss AmirChief Accounting OfficerMay 15 '24Sale16.8015,500260,41717,814May 17 07:41 AM
Weiss AmirChief Accounting OfficerMay 16 '24Sale16.6512,635210,3775,179May 17 07:41 AM
Conway Vikki LSee "Remarks"May 13 '24Sale16.7415,219254,8070May 15 08:36 AM
Kalif Eliyahu SharonEVP, Chief Financial OfficerMar 06 '24Sale13.5277,5501,048,119203,691Mar 07 04:27 PM
Daniell RichardExec. VP, European CommercialMar 05 '24Sale13.5248,629657,24069,770Mar 07 04:20 PM
Conway Vikki LSee "Remarks"Mar 05 '24Sale13.521,42719,28615,219Mar 07 04:16 PM
Sabag MarkEVP, International MarketsMar 05 '24Sale13.52100,0001,352,090382,590Mar 07 04:12 PM
Conway Vikki LSee "Remarks"Mar 04 '24Sale13.373,53247,2346,617Mar 05 04:39 PM
Francis Richard DPresident and CEOMar 04 '24Sale13.3431,061414,270123,295Mar 05 04:27 PM
Daniell RichardExec. VP, European CommercialMar 04 '24Sale13.3495,7621,277,20769,770Mar 05 04:21 PM
Hughes Eric ASee "Remarks"Mar 04 '24Sale13.348,045107,29916,855Mar 05 04:16 PM
Drape EricExecutive VP Global OperationsFeb 28 '24Sale13.129,815128,7349,701Mar 01 06:45 AM
Daniell RichardExec. VP, European CommercialFeb 28 '24Sale13.1220,599270,17669,770Mar 01 06:43 AM
Conway Vikki LSee "Remarks"Feb 28 '24Sale13.121,36617,9162,928Mar 01 06:40 AM
Drape EricExecutive VP Global OperationsFeb 16 '24Sale13.05173,2612,261,9051Feb 21 07:37 AM
Francis Richard DPresident and CEOFeb 15 '24Sale13.1574,530980,17487,125Feb 20 07:42 AM
Weiss AmirChief Accounting OfficerFeb 01 '24Sale12.3731,766392,95510,676Feb 05 07:49 AM